Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
77.56
+2.01 (2.66%)
At close: Jul 19, 2024, 4:00 PM
77.81
+0.25 (0.32%)
Pre-market: Jul 22, 2024, 7:24 AM EDT
Boston Scientific Revenue
Boston Scientific had revenue of $14.71B in the twelve months ending March 31, 2024, with 12.74% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.86B with 13.78% year-over-year growth. In the year 2023, Boston Scientific had annual revenue of $14.24B with 12.29% growth.
Revenue (ttm)
$14.71B
Revenue Growth
+12.74%
P/S Ratio
7.75
Revenue / Employee
$306,396
Employees
48,000
Market Cap
114.03B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | 10.74B | 912.00M | 9.28% |
Dec 31, 2018 | 9.82B | 775.00M | 8.57% |
Dec 31, 2017 | 9.05B | 662.00M | 7.89% |
Dec 31, 2016 | 8.39B | 909.00M | 12.16% |
Dec 31, 2015 | 7.48B | 97.00M | 1.31% |
Dec 31, 2014 | 7.38B | 237.00M | 3.32% |
Dec 31, 2013 | 7.14B | -106.00M | -1.46% |
Dec 31, 2012 | 7.25B | -373.00M | -4.89% |
Dec 31, 2011 | 7.62B | -184.00M | -2.36% |
Dec 31, 2010 | 7.81B | -382.00M | -4.67% |
Dec 31, 2009 | 8.19B | 138.00M | 1.71% |
Dec 31, 2008 | 8.05B | -307.00M | -3.67% |
Dec 31, 2007 | 8.36B | 536.00M | 6.85% |
Dec 31, 2006 | 7.82B | 1.54B | 24.48% |
Dec 31, 2005 | 6.28B | 659.00M | 11.72% |
Dec 31, 2004 | 5.62B | 2.15B | 61.80% |
Dec 31, 2003 | 3.48B | 557.00M | 19.08% |
Dec 31, 2002 | 2.92B | 246.00M | 9.20% |
Dec 31, 2001 | 2.67B | 9.00M | 0.34% |
Dec 31, 2000 | 2.66B | -178.00M | -6.26% |
Dec 31, 1999 | 2.84B | 608.00M | 27.22% |
Dec 31, 1998 | 2.23B | 403.00M | 22.01% |
Dec 31, 1997 | 1.83B | 279.76M | 18.03% |
Dec 31, 1996 | 1.55B | 360.42M | 30.27% |
Dec 31, 1995 | 1.19B | 302.25M | 34.02% |
Dec 31, 1994 | 888.57M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cigna | 206.00B |
Elevance Health | 171.96B |
HCA Healthcare | 66.72B |
Sanofi | 51.60B |
Bristol-Myers Squibb Company | 45.53B |
Medtronic | 32.36B |
Gilead Sciences | 27.45B |
Stryker | 20.96B |
BSX News
- 20 days ago - Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results - PRNewsWire
- 4 weeks ago - SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK - Business Wire
- 4 weeks ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. - PRNewsWire
- 4 weeks ago - Boston Scientific Buys Silk Road Medical for $1.26 Billion - Investopedia
- 4 weeks ago - Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal - Benzinga
- 4 weeks ago - Breaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal Terms - GlobeNewsWire
- 4 weeks ago - Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. - Barrons
- 4 weeks ago - Boston Scientific to buy Silk Road Medical in $1.16 billion deal - Reuters